BMO Cuts Halozyme (HALO) to Market Perform Following FDA's Request for More Info on HyQ Application
Go back to BMO Cuts Halozyme (HALO) to Market Perform Following FDA's Request for More Info on HyQ Application| Halozyme Therapeutics, Inc. (NASDAQ: HALO) | Delayed: 98.66 -2.01 (2%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $100.67 | 52 Week High | $18.39 | |||
| Open | $100.35 | 52 Week Low | $6.96 | |||
| Day High | $100.83 | P/E | N/A | |||
| Day Low | $98.13 | EPS | $-0.58 | |||
| Volume | 1,659,274 | |||||
